Learn More
SummaryWith the purpose of describing the MAb ior-R3’s kinetic behavior in disease state, this paper is focused on the study of this response using a human cancer (lung carcinoma cell line, H125)(More)
The multiple-dose strategy with the monoclonal ior EGF/r3 antibody, in xenograft bearing nude mice, was supported upon the basis of its integrated pharmacokinetic-pharmacodynamic relationship,(More)
  • 1